Enterome Bioscience

Nestle
Biotech

Nestlé wagers $41M on preclinical food allergy and IBD prospect

Nestlé is paying $41 million to co-develop Enterome’s preclinical IL-10 inducer and collaborate on the discovery of other food allergy candidates.
Nick Paul Taylor Jul 18, 2022 5:17am
Takeda HQ

Takeda buys stake in Enterome’s microbiome Crohn’s drug

Oct 23, 2018 2:00am
Paris

Enterome gets €32M, Bristol-Myers backing, for cancer work

Jan 4, 2018 3:00am

Nestlé, Enterome form microbiome diagnostic joint venture

Jul 11, 2017 2:00am
Bristol-Myers Squibb building

Bristol-Myers, Enterome pen microbiome I/O research pact

Nov 16, 2016 4:08am